IT Versione italiana

scientific meetings » ICML 2019 - Lugano


15th edition of the International Conference on Malignant Lymphoma

From 18.06.2019 to 22.06.2019    Lugano

The 15-ICML gathered almost 3,800 physicians in Lugano from all over the world: hematologists, clinical oncologists, radiation oncologists, pediatricians, pathologists and leading researchers involved in the study and treatment of lymphoid neoplasms. The Swiss scientific event is now considered the world's leading forum on both basic and clinical research for the sixth most common cancer pathology in humans.



interviews

[en] The efficacy of Liquid Biopsy in the detection of blood tumor DNA
Prof. R. Dalla Favera
[en] State of the art of treatments in chronic lymphocytic leukemia
Prof. Michael Hallek
[en] Lenalidomide/R‐CHOP fase II study results
Dr. G. Nowakowski
[en] Efficacy and fields of application of the CAR-T cell therapy
Prof. Davide Rossi
[en] B-cell lymphoma: the efficacy and safety of ADCT-402
Prof. John Radford
[en] Large B-cell lymphoma: two studies compared
Prof. Anas Younes
[en] B-cell Non-Hodgkin's Lymphoma: treatment with new antibodies
Dr. Michael Dickinson
[en] Camidanlumab Tesirine in Classical Hodgkin Lymphoma
Dr. Graham Collins
[en] Liquid Biopsy: the very first world workshop on this new technology
Prof. Davide Rossi

press conference highlights

[en] Moving forward in chronic lymphocytic leukemia treatment
Prof. Michael Hallek
[en] Moving forward in aggressive lymphoma
Dr. G. Nowakowski
[en] Gene therapy for lymphomas and Liquid Biopsy
Prof. Davide Rossi
[en] Questions & Answers: the difference between CAR-T and bio-specific cells
[en] Questions & Answers: the CAR-T cell therapy situation in Switzerland
[en] Questions & Answers: Chronic lymphocytic leukemia, treatment of asymptomatic patient
[] Questions & Answers: CLL, appropriateness of placebo in this type of study
[en] Questions & Answers: Incidence of lenalidomide dosage on study results


Cookies helps us to provide our services. Using these services , you agree to use of cookies on our part. OK